Literature DB >> 21468207

The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of mice.

Mark Fenton1, Pat G Casey, Colin Hill, Cormac Gm Gahan, R Paul Ross, Olivia McAuliffe, Jim O'Mahony, Fiona Maher, Aidan Coffey.   

Abstract

The endolysin LysK derived from staphylococcal phage K has previously been shown to have two enzymatic domains, one of which is an N-acetylmuramoyl-L-alanine amidase and the other a cysteine/histidine-dependant amidohydrolase/peptidase designated CHAP(k). The latter, when cloned as a single-domain truncated enzyme, is conveniently overexpressed in a highly-soluble form. This enzyme was shown to be highly active in vitro against live cell suspensions of S. aureus. In the current study, the IVIS imaging system was used to demonstrate the effective elimination of a lux labeled S. aureus from the nares of BALB/c mice.
© 2010 Landes Bioscience

Entities:  

Keywords:  Staphylococcus; bacteriophage; decolonization; lysin; nasal

Mesh:

Substances:

Year:  2010        PMID: 21468207      PMCID: PMC3056090          DOI: 10.4161/bbug.1.6.13422

Source DB:  PubMed          Journal:  Bioeng Bugs        ISSN: 1949-1018


  31 in total

1.  Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci.

Authors:  Marianne Horgan; Gary O'Flynn; Jennifer Garry; Jakki Cooney; Aidan Coffey; Gerald F Fitzgerald; R Paul Ross; Olivia McAuliffe
Journal:  Appl Environ Microbiol       Date:  2008-12-01       Impact factor: 4.792

2.  Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk.

Authors:  José María Obeso; Beatriz Martínez; Ana Rodríguez; Pilar García
Journal:  Int J Food Microbiol       Date:  2008-08-26       Impact factor: 5.277

3.  Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats.

Authors:  J M Entenza; J M Loeffler; D Grandgirard; V A Fischetti; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin.

Authors:  David M Donovan; Michelle Lardeo; Juli Foster-Frey
Journal:  FEMS Microbiol Lett       Date:  2006-10-19       Impact factor: 2.742

5.  Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11.

Authors:  Mohammad Rashel; Jumpei Uchiyama; Takako Ujihara; Yoshio Uehara; Shu Kuramoto; Shigeyoshi Sugihara; Ken-Ichi Yagyu; Asako Muraoka; Motoyuki Sugai; Keiichi Hiramatsu; Koichi Honke; Shigenobu Matsuzaki
Journal:  J Infect Dis       Date:  2007-09-11       Impact factor: 5.226

6.  Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis.

Authors:  Denis Grandgirard; Jutta M Loeffler; Vincent A Fischetti; Stephen L Leib
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

Review 7.  Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review.

Authors:  Miranda M L van Rijen; Marc Bonten; Richard P Wenzel; Jan A J W Kluytmans
Journal:  J Antimicrob Chemother       Date:  2008-01-03       Impact factor: 5.790

8.  Antimicrobial activity of a chimeric enzybiotic towards Staphylococcus aureus.

Authors:  Salim Manoharadas; Angela Witte; Udo Bläsi
Journal:  J Biotechnol       Date:  2008-09-26       Impact factor: 3.307

9.  The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.

Authors:  Stephen C Becker; Juli Foster-Frey; David M Donovan
Journal:  FEMS Microbiol Lett       Date:  2008-08-21       Impact factor: 2.742

10.  Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae.

Authors:  Jonathan A McCullers; Asa Karlström; Amy R Iverson; Jutta M Loeffler; Vincent A Fischetti
Journal:  PLoS Pathog       Date:  2007-03       Impact factor: 6.823

View more
  35 in total

Review 1.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

2.  Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.

Authors:  Mathias Schmelcher; Yang Shen; Daniel C Nelson; Marcel R Eugster; Fritz Eichenseher; Daniela C Hanke; Martin J Loessner; Shengli Dong; David G Pritchard; Jean C Lee; Stephen C Becker; Juli Foster-Frey; David M Donovan
Journal:  J Antimicrob Chemother       Date:  2015-01-27       Impact factor: 5.790

3.  Nonconventional Therapeutics against Staphylococcus aureus.

Authors:  Caroline M Grunenwald; Monique R Bennett; Eric P Skaar
Journal:  Microbiol Spectr       Date:  2018-11

Review 4.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

Review 5.  Antimicrobial bacteriophage-derived proteins and therapeutic applications.

Authors:  Dwayne R Roach; David M Donovan
Journal:  Bacteriophage       Date:  2015-06-23

6.  Production of bacteriophage-encoded endolysin, LysP11, in Nicotiana benthamiana and its activity as a potent antimicrobial agent against Erysipelothrix rhusiopathiae.

Authors:  Md Reyazul Islam; Namil Son; Junho Lee; Dong Wook Lee; Eun-Ju Sohn; Inhwan Hwang
Journal:  Plant Cell Rep       Date:  2019-08-20       Impact factor: 4.570

7.  In silico modeling of the staphylococcal bacteriophage-derived peptidase CHAP(K).

Authors:  Mark Fenton; Jakki C Cooney; R Paul Ross; Roy D Sleator; Olivia McAuliffe; Jim O'Mahony; Aidan Coffey
Journal:  Bacteriophage       Date:  2011-07-01

8.  Bacteriophage-Derived Peptidase CHAP(K) Eliminates and Prevents Staphylococcal Biofilms.

Authors:  Mark Fenton; Ruth Keary; Olivia McAuliffe; R Paul Ross; Jim O'Mahony; Aidan Coffey
Journal:  Int J Microbiol       Date:  2013-02-03

Review 9.  Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus.

Authors:  Piotr Szweda; Marta Schielmann; Roman Kotlowski; Grzegorz Gorczyca; Magdalena Zalewska; Slawomir Milewski
Journal:  Appl Microbiol Biotechnol       Date:  2012-10-18       Impact factor: 4.813

10.  Potential of the virion-associated peptidoglycan hydrolase HydH5 and its derivative fusion proteins in milk biopreservation.

Authors:  Lorena Rodríguez-Rubio; Beatriz Martínez; David M Donovan; Pilar García; Ana Rodríguez
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.